QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Subsidiary Receives Health Canada Approval for Vanluven Road Facility Expansion

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Thursday announced that its wholly-owned subsidiary, ABcann Medicinals Inc., received approval from Health Canada to commence cultivation in the expansion of its Vanluven Road facility in Napanee. The expansion includes production and product development space built to GMP standards and doubles the company’s Ontario cultivation capacity. Cultivation in the expanded area will begin immediately. In addition, the company has incorporated a supercritical CO2 extraction suite for production of concentrates into the facility, which is expected to be brought on-line mid-2019. “The GMP certification of our Vanluven expansion, expected later this year, will enable us to service the growing international medical cannabis market. We are excited to build on our success by introducing new high-margin, value-added products which leverage our increased production capabilities and tap into the user insights gained from our vast Harvest Medicine Clinic patient network,” VIVO CEO Barry Fishman stated in the news release.

To view the full press release, visit http://ibn.fm/0kM98

About VIVO Cannabis(TM)

VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF